Table 2

Prevalence of medical comorbidities among patients with ankylosing spondylitis compared with controls (n=70 206)

VariablePatients with ankylosing spondylitis (n=11 701)Patients without ankylosing spondylitis (n=58 505)p Value
Cardiovascular
 Hypertension1920 (16.4)6224 (10.6)<0.001
 Ischaemic heart disease102 (0.9)190 (0.3)<0.001
 Hyperlipidaemia1009 (8.6)3641 (6.2)<0.001
 Congestive heart failure132 (1.1)470 (0.8)<0.001
 Cardiac arrhythmias279 (2.4)784 (1.3)<0.001
 Peripheral vascular disorder88 (0.8)322 (0.6)<0.001
 Stroke226 (1.9)1123 (1.9)0.931
Neurological
 Paralysis57 (0.5)240 (0.4)0.242
 Other neurological disorders116 (1.0)565 (1.0)0.796
 Headache1191 (10.2)5404 (9.2)<0.001
 Migraine150 (1.3)418 (0.7)<0.001
Pulmonary
 COPD68 (0.6)107 (0.2)<0.001
 Asthma362 (3.1)1841 (3.2)0.764
 Restrictive/interstitial lung disease25 (0.2)116 (0.2)0.734
Endocrine
 Diabetes without complications557 (4.8)2550 (4.4)0.054
 Diabetes with complications165 (1.4)894 (1.5)0.339
 Hypothyroidism301 (2.6)744 (1.3)<0.001
 Obesity18 (0.2)105 (0.2)0.545
 Weight loss6 (0.1)38 (0.1)0.590
Renal
 Renal failure77 (0.7)348 (0.6)0.421
 Fluid and electrolyte disorders63 (0.54)374 (0.6)0.206
Gastrointestinal
 Liver disease1173 (10.0)3223 (5.5)<0.001
 Peptic ulcer1623 (13.9)2581 (4.4)<0.001
Viral/infectious
 Hepatitis454 (3.9)1147 (2.0)<0.001
 HIV8 (0.1)36 (0.1)0.787
 Tuberculosis49 (0.4)144 (0.3)0.001
Haematology
 Deficiency anaemias275 (2.4)517 (0.9)<0.001
Drug abuse/dependence
 Alcohol37 (0.3)138 (0.2)0.112
 Drug128 (1.1)585 (1.0)0.311
Mental illness
 Depression301 (2.6)776 (1.3)<0.001
 Psychoses249 (2.1)763 (1.3)<0.001
Oncology
 Metastatic cancer5 (0.0)35 (0.1)0.479
 Solid tumour without metastasis146 (1.3)729 (1.3)0.988
  • Data shown as n (%).

  • COPD, chronic obstructive pulmonary disease.